3 studies found for:    16115903 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel, Anthracycline (Doxorubicin or Epirubicin), Cyclophosphamide;   Drug: Docetaxel, cyclophosphamide
2 Recruiting Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Veliparib
3 Completed Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Paclitaxel, Carboplatin

Indicates status has not been verified in more than two years